InsiderClue
← All stocks

Neurogene Inc.

NGNE Net buying
CIK 0001404644 #2786 in the set updated 19 Sep 2026
Bought (120 mo)
$83.26M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$2.33M
$1.31M on a plan · $277.42K straight out of an exercise
Sold at will
$738.10K
36 of 61 sales
Net
+$80.93M
+$82.52M against sales at will

By person

15 insiders · 134 transactions
78.4×

Rachel McMinn holds 78.4 times base salary in stock. $48.58M of shares against $618.80K in salary for 2025.

Salary from the company's own proxy. The shares are what Rachel McMinn last reported holding, valued at $36.13, the price Common Stock was last bought or sold at on the open market here, on 7 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
BAKER BROS. ADVISORS LP entity
Director
$75.34M (49)
—
+$75.34M
5,162,141
25.80%
$186.53M
−16.9%
DRACHMAN JONATHAN G
President and CEO
$3.19M (9)
—
+$3.19M
2,373,686
11.86%
$85.77M
+1,010%
Redmile Group, LLC entity
10% owner
$2.01M (9)
$220.15K (4)
+$1.79M
4,041,211
20.19%
$146.03M
+4.5%
Samsara BioCapital GP, LLC entity
10% owner
$1.26M (4)
—
+$1.26M
1,717,127
8.58%
$62.05M
+2.9%
McMinn Rachel
Chief Executive Officer
$969.00K (1)
$74.00K (1) scheduled
+$895.00K
1,344,307
6.72%
$48.58M
+7.5%
Cvijic Christine Mikail
President and CFO
$491.40K (1)
$976.27K (13) scheduled
−$484.87K
84,040
0.4200%
$3.04M
+301.3%
Walkey Carl
Senior Vice President
—
$425.64K (26)
−$425.64K
1,352,489
6.76%
$48.87M
−2.5%
Cobb Stuart
Chief Scientific Officer
—
$244.45K (4) scheduled
−$244.45K
30,497
0.1524%
$1.10M
—
Main David
President and CEO
—
$207.24K (3) scheduled
−$207.24K
71,530
0.3574%
$2.58M
0.0%
Ho Robert
Chief Financial Officer
—
$71.56K (1)
−$71.56K
21,503
0.1075%
$776.99K
+616.8%
LEVITT DANIEL J
Director
—
$49.49K (1) scheduled
−$49.49K
0
0.0000%
$0.00
—
MacKenzie Lloyd
Chief Operating Officer
—
$19.05K (1) scheduled
−$19.05K
0
0.0000%
$0.00
—
Jordan Julie
Chief Medical Officer
—
$18.13K (1) scheduled
−$18.13K
12,472
0.0623%
$450.66K
—
Patel Priti
Former Chief Medical Officer
—
$17.94K (3)
−$17.94K
37,313
0.1865%
$1.35M
+521.9%
Smith Sean Michael
Interim CFO, Prin Acct Off
—
$4.44K (3)
−$4.44K
21,637
0.1081%
$781.83K
+298.4%

Individual transactions

73
Insider
Date
Role
Action
Shares
Price
Amount
Samsara BioCapital GP, LLC
26 Nov 2024
10% owner
Buy indirect
2,000
$27.50
$55.00K
Samsara BioCapital GP, LLC
26 Nov 2024
10% owner
Buy indirect
15,219
$26.73
$406.80K
Samsara BioCapital GP, LLC
26 Nov 2024
10% owner
Buy indirect
10,803
$26.01
$280.99K
Samsara BioCapital GP, LLC
26 Nov 2024
10% owner
Buy indirect
20,748
$24.91
$516.83K
McMinn Rachel
22 Nov 2024
Chief Executive Officer
Buy
47,500
$20.40
$969.00K
Cvijic Christine Mikail
22 Nov 2024
President and CFO
Buy
24,000
$20.48
$491.40K
BAKER BROS. ADVISORS LP
17 Aug 2023
Director
Buy indirect
61,134
$0.69
$42.35K
BAKER BROS. ADVISORS LP
17 Aug 2023
Director
Buy indirect
5,041
$0.69
$3.49K
BAKER BROS. ADVISORS LP
17 Aug 2023
Director
Buy indirect
93,091
$0.69
$64.46K
BAKER BROS. ADVISORS LP
17 Aug 2023
Director
Buy indirect
7,676
$0.69
$5.31K
BAKER BROS. ADVISORS LP
16 Aug 2023
Director
Buy indirect
4,434
$0.68
$3.03K
BAKER BROS. ADVISORS LP
16 Aug 2023
Director
Buy indirect
366
$0.68
$249.90
BAKER BROS. ADVISORS LP
16 Aug 2023
Director
Buy indirect
207,676
$0.68
$141.32K
BAKER BROS. ADVISORS LP
16 Aug 2023
Director
Buy indirect
17,124
$0.68
$11.65K
BAKER BROS. ADVISORS LP
15 Aug 2023
Director
Buy indirect
4,342
$0.67
$2.89K
BAKER BROS. ADVISORS LP
15 Aug 2023
Director
Buy indirect
358
$0.67
$238.07
BAKER BROS. ADVISORS LP
15 Aug 2023
Director
Buy indirect
1,740,581
$0.63
$1.10M
BAKER BROS. ADVISORS LP
15 Aug 2023
Director
Buy indirect
143,519
$0.63
$90.53K
DRACHMAN JONATHAN G
25 Aug 2021
President and CEO
Buy indirect
25,000
$6.45
$161.23K
DRACHMAN JONATHAN G
25 Aug 2021
President and CEO
Buy indirect
25,000
$6.45
$161.23K
DRACHMAN JONATHAN G
24 Aug 2021
President and CEO
Buy
100,000
$6.11
$611.10K
DRACHMAN JONATHAN G
4 Jun 2021
President and CEO
Buy
10,000
$9.61
$96.08K
DRACHMAN JONATHAN G
3 Jun 2021
President and CEO
Buy
40,000
$9.48
$379.27K
BAKER BROS. ADVISORS LP
7 Jul 2020
Director
Buy indirect
394,360
$15.25
$6.01M
BAKER BROS. ADVISORS LP
7 Jul 2020
Director
Buy indirect
29,640
$15.25
$452.01K
Redmile Group, LLC
2 Apr 2020
10% owner
Buy indirect
1,000
$11.85
$11.85K
Redmile Group, LLC
2 Apr 2020
10% owner
Buy indirect
38,300
$11.36
$435.11K
Redmile Group, LLC
1 Apr 2020
10% owner
Buy indirect
9,000
$11.65
$104.87K
Redmile Group, LLC
1 Apr 2020
10% owner
Buy indirect
33,500
$10.95
$366.76K
Redmile Group, LLC
31 Mar 2020
10% owner
Buy indirect
7,500
$10.71
$80.31K
Redmile Group, LLC
31 Mar 2020
10% owner
Buy indirect
22,500
$10.18
$229.08K
Redmile Group, LLC
30 Mar 2020
10% owner
Buy indirect
2,700
$10.27
$27.74K
Redmile Group, LLC
30 Mar 2020
10% owner
Buy indirect
29,800
$9.91
$295.17K
Redmile Group, LLC
27 Mar 2020
10% owner
Buy indirect
50,000
$9.21
$460.40K
BAKER BROS. ADVISORS LP
20 Dec 2019
Director
Buy indirect
2,767,505
$8.40
$23.25M
BAKER BROS. ADVISORS LP
20 Dec 2019
Director
Buy indirect
250,037
$8.40
$2.10M
DRACHMAN JONATHAN G
20 Dec 2019
President and CEO
Buy
119,047
$8.40
$999.99K
DRACHMAN JONATHAN G
11 Sep 2019
See Remarks
Buy
136,436
$3.30
$449.90K
DRACHMAN JONATHAN G
10 Sep 2019
See Remarks
Buy
36,742
$3.08
$113.29K
DRACHMAN JONATHAN G
9 Sep 2019
See Remarks
Buy
76,822
$2.85
$218.56K
BAKER BROS. ADVISORS LP
7 Aug 2019
Director
Buy indirect
50,436
$3.15
$159.02K
BAKER BROS. ADVISORS LP
7 Aug 2019
Director
Buy indirect
4,564
$3.15
$14.39K
BAKER BROS. ADVISORS LP
7 Aug 2019
Director
Buy indirect
209,382
$3.02
$633.25K
BAKER BROS. ADVISORS LP
7 Aug 2019
Director
Buy indirect
18,943
$3.02
$57.29K
BAKER BROS. ADVISORS LP
7 Aug 2019
Director
Buy indirect
5,869
$2.96
$17.36K
BAKER BROS. ADVISORS LP
7 Aug 2019
Director
Buy indirect
531
$2.96
$1.57K
BAKER BROS. ADVISORS LP
6 Aug 2019
Director
Buy indirect
65,568
$2.85
$186.67K
BAKER BROS. ADVISORS LP
6 Aug 2019
Director
Buy indirect
5,932
$2.85
$16.89K
BAKER BROS. ADVISORS LP
6 Aug 2019
Director
Buy indirect
9,445
$2.83
$26.76K
BAKER BROS. ADVISORS LP
6 Aug 2019
Director
Buy indirect
855
$2.83
$2.42K
BAKER BROS. ADVISORS LP
9 Jan 2017
10% owner
Buy indirect
32,051
$17.76
$569.23K
BAKER BROS. ADVISORS LP
9 Jan 2017
10% owner
Buy indirect
3,389
$17.76
$60.19K
BAKER BROS. ADVISORS LP
9 Jan 2017
10% owner
Buy indirect
235,169
$17.60
$4.14M
BAKER BROS. ADVISORS LP
9 Jan 2017
10% owner
Buy indirect
24,871
$17.60
$437.72K
BAKER BROS. ADVISORS LP
9 Jan 2017
10% owner
Buy indirect
35,360
$16.31
$576.56K
BAKER BROS. ADVISORS LP
9 Jan 2017
10% owner
Buy indirect
3,739
$16.31
$60.97K
BAKER BROS. ADVISORS LP
9 Jan 2017
10% owner
Buy indirect
5,006
$15.62
$78.21K
BAKER BROS. ADVISORS LP
9 Jan 2017
10% owner
Buy indirect
529
$15.62
$8.26K
BAKER BROS. ADVISORS LP
9 Jan 2017
10% owner
Buy indirect
15,148
$15.13
$229.19K
BAKER BROS. ADVISORS LP
9 Jan 2017
10% owner
Buy indirect
1,602
$15.13
$24.24K
BAKER BROS. ADVISORS LP
9 Jan 2017
10% owner
Buy indirect
9,143
$16.20
$148.09K
BAKER BROS. ADVISORS LP
9 Jan 2017
10% owner
Buy indirect
967
$16.20
$15.66K
BAKER BROS. ADVISORS LP
9 Jan 2017
10% owner
Buy indirect
8,671
$15.35
$133.08K
BAKER BROS. ADVISORS LP
9 Jan 2017
10% owner
Buy indirect
917
$15.35
$14.07K
BAKER BROS. ADVISORS LP
9 Jan 2017
10% owner
Buy indirect
2,442
$16.85
$41.16K
BAKER BROS. ADVISORS LP
9 Jan 2017
10% owner
Buy indirect
258
$16.85
$4.35K
BAKER BROS. ADVISORS LP
9 Jan 2017
10% owner
Buy indirect
11,305
$15.32
$173.20K
BAKER BROS. ADVISORS LP
9 Jan 2017
10% owner
Buy indirect
1,195
$15.32
$18.31K
BAKER BROS. ADVISORS LP
9 Jan 2017
10% owner
Buy indirect
5,697
$16.74
$95.36K
BAKER BROS. ADVISORS LP
9 Jan 2017
10% owner
Buy indirect
603
$16.74
$10.09K
BAKER BROS. ADVISORS LP
20 Sep 2016
10% owner
Buy indirect
12,550
$13.15
$165.03K
BAKER BROS. ADVISORS LP
20 Sep 2016
10% owner
Buy indirect
2,476,348
$12.25
$30.34M
BAKER BROS. ADVISORS LP
20 Sep 2016
10% owner
Buy indirect
294,707
$12.25
$3.61M
Show all 134 transactions →

What was left out

Form 4 filings counted 178
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 17
Sales on a Rule 10b5-1 plan 19
Sales straight out of an exercise 6
Sales at will 36
Transactions with no price 0
Shares from compensation/vesting 13,438,930
Sales filed before the plan box existed 34
History held since 21 Sep 2016